First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.26 USD -4.05% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Tax Provision Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Tax Provision
-$39.1m
CAGR 3-Years
-407%
CAGR 5-Years
-187%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Tax Provision
-CHf10k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Tax Provision
-$2.9m
CAGR 3-Years
-53%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Tax Provision
-CHf10k
CAGR 3-Years
43%
CAGR 5-Years
45%
CAGR 10-Years
10%
Idorsia Ltd
SIX:IDIA
Tax Provision
-CHf7.8m
CAGR 3-Years
6%
CAGR 5-Years
-111%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Tax Provision
-CHf380k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Tax Provision?
Tax Provision
-39.1m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Tax Provision amounts to -39.1m USD.

What is ADC Therapeutics SA's Tax Provision growth rate?
Tax Provision CAGR 5Y
-187%

Over the last year, the Tax Provision growth was -3 455%. The average annual Tax Provision growth rates for ADC Therapeutics SA have been -407% over the past three years , -187% over the past five years .